Abstract PD5-07: Comprehensive profiling of poor-risk paired primary and recurrent triple-negative breast cancers reveals immune phenotype shifts
Yuan, Y, Yost, SE, Chang, C-W, Yoh, KE, Johnson, RM, Schmolze, D, Liang, J, Hutchinson, KE
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P2-10-01: Genomic profiling of residual ER+ breast cancers treated with prolonged neoadjuvant letrozole reveals novel alterations in clinically resistant tumors
Guerrero, AL, Stricker, T, Hutchinson, KE, Formisano, L, Giltnane, J, Fidalgo, A, Schwarz, LJ, Gavila, J, Guillen, V, Lluch, A, Ruiz, A, Arteaga, CL
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract PD5-02: Not presented
Guerrero-Zotano, AL, Stricker, TP, Hutchinson, KE, Stover, DG, Formisano, L, Lee, K-M, Schwarz, LJ, Giltnane, JM, Jansen, VM, Gavila, J, Perez-Fidalgo, A, Lluch, A, Llombart, A, Bayar, MA, Michiels, S, André, F, Arnedos, M, Ruiz, A, Arteaga, CL
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Abstract P6-12-09: Pan-HER, an antibody mixture with antitumor activity against drug-resistant HER2-overexpressing breast cancers with high ERBB ligand expression
Schwarz, LJ, Hutchinson, KE, Estrada, MV, Sanders, ME, Dugger, TC, Formisano, L, Guerrero, AL, Red-Brewer, M, Young, CD, Lantto, J, Pedersen, MW, Kragh, M, Horak, ID, Arteaga, CL
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article